- B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer
FEN LIU et al, 2015 CrossRef - B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance
CHENGLIN HUANG et al, 2016 CrossRef - Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis
WEI DAI et al, 2014 CrossRef - B7 homolog 3 aggravates brain injury in a murine model of Streptococcus pneumoniae-induced meningitis
XUQIN CHEN et al, 2015 CrossRef - Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
Ting Zhang, 2015, WJG CrossRef - Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
Shiro Kimbara et al, 2016, WJG CrossRef - Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness
Fabrizio Marcucci et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - 212 Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Benjamin B. Kasten et al, 2017, Nuclear Medicine and Biology CrossRef - B7-H3 in tumors: friend or foe for tumor immunity?
Gen Li et al, 2018, Cancer Chemother Pharmacol CrossRef - B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis
Yi Li et al, 2017 CrossRef - B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity
WEI ZHANG et al, 2015 CrossRef - Advances of Immune Checkpoint Inhibitors in Tumor Immunotherapy
Qiao Guo, 2018, IOP Conf. Ser.: Mater. Sci. Eng. CrossRef - Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
Jingyi Wu et al, 2018, Eur J Surg Oncol CrossRef - Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells
Pengfei Zhang et al, 2017, Biochemical and Biophysical Research Communications CrossRef - B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
Peixin Dong et al, 2018, Front. Oncol. CrossRef - Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
Kentaro Inamura et al, 2018, JCM CrossRef - Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody
Wanru Ma et al, 2018, Cancer Med CrossRef - Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection
Fei Gao et al, 2018, Viral Immunology CrossRef - MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7 H3
Xiao-wen Zhu et al, 2018, Biochemical and Biophysical Research Communications CrossRef - Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
Wang Manni et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276
Lawrence A. Stern et al, 2019, ACS Comb. Sci. CrossRef - B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma
Jingyuan Zhao et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef -
A risk assessment model of acute liver allograft rejection by genetic polymorphism of
CD
276
Xiaobo Yu et al, 2019, Mol Genet Genomic Med CrossRef - How much information can be obtained from tracking the position of the leading edge in a scratch assay?
Stuart T. Johnston et al, 2014, J. R. Soc. Interface CrossRef - Emerging Co-signaling Networks in T Cell Immune Regulation
Keunok Jung et al, 2013, Immune Netw CrossRef - B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
Vibeke A Ingebrigtsen et al, 2014, BMC Cancer CrossRef - Epithelial and Tumor-associated Endothelial Expression of B7-H3 in Cervical Carcinoma
Hermann Brustmann et al, 2015, International Journal of Gynecological Pathology CrossRef - B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
Fu-biao Kang et al, 2015, Cancer Cell Int CrossRef - ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer
Pei Zhang et al, 2015 CrossRef - B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway
Bo Jiang et al, 2016, Tumor Biol. CrossRef - New checkpoints in cancer immunotherapy
Ling Ni et al, 2017, Immunol Rev CrossRef - Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies
Jeong A. Park et al, 2017, Cancer Treatment Reviews CrossRef - null
Yaping Zhang et al, 2020 CrossRef - MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer
Zheng-Shi Wang et al, 2016, Oncotarget CrossRef - B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells
Dongbao Li et al, 2017, Oncotarget CrossRef - Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis
Xianyun Zhang et al, 2017, Oncotarget CrossRef - Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
Caroline E. Nunes-Xavier et al, 2016, Oncotarget CrossRef - B7-H3 promotes gastric cancer cell migration and invasion
Yecheng Li et al, 2017, Oncotarget CrossRef - The potentials of immune checkpoints for the treatment of blood malignancies
Mohsen Alizadeh et al, 2020, Critical Reviews in Oncology/Hematology CrossRef - Clinical relevance of B7H3 expression in retinoblastoma
Bhuvaneswari Ganesan et al, 2020, Sci Rep CrossRef - Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Paolo D’Arrigo et al, 2020, CMC CrossRef - High B7‐H3 expression is linked to increased risk of prostate cancer progression
Sarah Bonk et al, 2020, Pathology International CrossRef - Varied functions of immune checkpoints during cancer metastasis
Ali Safarzadeh et al, 2020, Cancer Immunol Immunother CrossRef - B7-H3 Immune Checkpoint Protein in Human Cancer
Karine Flem-Karlsen et al, 2020, CMC CrossRef - Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer
Yue Fan et al, 2020, Computational and Mathematical Methods in Medicine CrossRef - Molecular mechanisms of breast cancer chemoresistance by immune checkpoints
Narges Dastmalchi et al, 2020, Life Sciences CrossRef - B7-H3 targeted antibody-based immunotherapy of malignant diseases
Theodoros Michelakos et al, 2020, Expert Opinion on Biological Therapy CrossRef - Breast Cancer Detection by B7-H3–Targeted Ultrasound Molecular Imaging
Sunitha V. Bachawal et al, 2015, Cancer Res CrossRef - Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
Sangbin Lim et al, 2016, Cancer Res CrossRef - B7-H3 and digestive system cancers
Liyun Zhou et al, 2021, Eur J Inflamm CrossRef - The Role of CD276 in Cancers
Shengzhuo Liu et al, 2021, Front. Oncol. CrossRef - The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role
Marina Digregorio et al, 2021, acta neuropathol commun CrossRef - Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer
Emma E. Geerdes et al, 2021, Front. Oncol. CrossRef - An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
Raefa Abou Khouzam et al, 2021, Front. Immunol. CrossRef - Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Jan P. Bogen et al, 2021, Front. Oncol. CrossRef - MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy
Jin Wang et al, 2021, Mol Biotechnol CrossRef - The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Bradley I. Reinfeld et al, 2021, Cell Mol Immunol CrossRef - 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer
Mengshi Li et al, 2020, CMC CrossRef - Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer
Lihua Xu et al, 2013, Cancer Cell Int CrossRef - B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models
Baozhu Huang et al, 2020, OncoImmunology CrossRef - Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
Kinga Hińcza-Nowak et al, 2021, Genes CrossRef - Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma
Wanzun Lin et al, 2021, Front. Immunol. CrossRef - Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
Wei Zhang et al, 2021, Bioengineered CrossRef - Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
Chao Xia et al, 2022, Front. Immunol. CrossRef - Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer
Shuping Si et al, 2022, BMC Cancer CrossRef - B7-H3-targeted CAR-T cell therapy for solid tumors
Guangfei Li et al, 2022, International Reviews of Immunology CrossRef - The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
Pengfei Xu et al, 2022, Biomedicines CrossRef - Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future
Ling Wang et al, 2022, Front. Oncol. CrossRef - Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 Interaction
Pujan Sasmal et al, 2022, Bioorganic & Medicinal Chemistry CrossRef - B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy
Xin Chen et al, 2022, IJMS CrossRef - Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta et al, 2023, Biology CrossRef - mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
Heng-Jia Liu et al, 2023, Nat Commun CrossRef - IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
Martina S. Lutz et al, 2023, Front. Immunol. CrossRef - Bioinformatics-Based Identification of B7-H Family Genes and Related Clinicopathological Parameters in Colorectal Cancer
Rui Chen et al, 2022, SSRN Journal CrossRef - B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival
Salwa Alhamad et al, 2023, Cancers CrossRef - Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis
Yu Ri Seo et al, 2023, Sci Rep CrossRef - A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
Huiting Wu et al, 2023, OncoImmunology CrossRef - A Novel Pyroptosis-Based Prognostic Model Correlated with the Parainflammatory Immune Microenvironment of Pancreatic Cancer
Kong-kong Wei et al, 2023, Journal of Immunology Research CrossRef - New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
Ioannis-Alexios Koumprentziotis et al, 2024, Vaccines CrossRef - An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer
Martina S. Lutz et al, 2024, Front. Immunol. CrossRef - Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis
Haohao sun et al, 2024, BMC Urol CrossRef